In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi

FEMS Microbiology Letters
Ildikó NyilasiCsaba Vágvölgyi

Abstract

The treatment of opportunistic fungal infections is often difficult as the number of available antifungal agents is limited. Nowadays, there is increasing interest in the investigation of the antifungal activity of nonantifungal drugs, and in the development of efficient antifungal combination therapy. In this study, the in vitro interactions of the effects of various statins (lovastatin, simvastatin, fluvastatin, atorvastatin (ATO), rosuvastatin (ROS) and pravastatin) and various azole antifungals [miconazole, ketoconazole, itraconazole and fluconazole (FLU)] against different opportunistic pathogenic fungi were investigated using a standard chequerboard broth microdilution method. When the investigated strains were sensitive to both compounds of the combination, additive interactions were frequently noticed. Synergistic interactions were observed in many cases when a strain was sensitive only to the azole compound (as in certain combinations with ATO or ROS) or the statin compound (as in certain combinations with FLU). In many combinations with an additive effect, the concentrations of drugs needed for total growth inhibition could be decreased by several dilution steps. Similar interactions were observed when the variability...Continue Reading

References

Sep 1, 1990·Antimicrobial Agents and Chemotherapy·R T Lorenz, L W Parks
Feb 1, 1995·Journal of Clinical Pharmacology·J TriscariH Y Pan
Oct 1, 1993·Clinical Microbiology Reviews·J H RexJ N Galgiani
Aug 5, 1998·British Journal of Clinical Pharmacology·K T KivistöP J Neuvonen
Feb 12, 1999·Fungal Genetics and Biology : FG & B·L V Roze, J E Linz
May 4, 1999·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·C Viscoli, E Castagnola
Sep 17, 1999·Archives of Physical Medicine and Rehabilitation·K A Stolp-Smith, R L Harmon
Feb 7, 2001·Clinical Microbiology Reviews·J A RibesD J Baker
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·T J Walsh, A H Groll
Oct 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N Singh
Jan 15, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideyo YamaguchiToshiyuki Matsunaga
Jul 29, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Afeltra, P E Verweij
Nov 6, 2004·Journal of Clinical Microbiology·Gyöngyi LukácsCsaba Vágvölgyi
Nov 24, 2004·Journal of Atherosclerosis and Thrombosis·Takashi MiidaYuichi Nakamura
Jan 11, 2005·Current Opinion in Infectious Diseases·Richard N GreenbergJulie A Ribes
Jan 22, 2005·Fundamental & Clinical Pharmacology·Michael Schachter
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·James K Liao, Ulrich Laufs
Apr 20, 2005·Journal of the American College of Cardiology·Rainer Schulz
Aug 9, 2005·The Journal of Biological Chemistry·Andrew CordleGary Landreth
Aug 10, 2005·Seminars in Respiratory and Critical Care Medicine·Alison G Freifeld, Peter C Iwen
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Georgios ChamilosDimitrios P Kontoyiannis
Jul 4, 2006·American Journal of Ophthalmology·Tina Rutar, Kimberly P Cockerham
Aug 16, 2006·FEMS Microbiology Letters·Ian G MacreadiePeter I Macreadie
Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P Kontoyiannis
Dec 7, 2007·Diagnostic Microbiology and Infectious Disease·Suganthini Krishnan NatesanElias K Manavathu
Jan 29, 2008·Recent Patents on Anti-infective Drug Discovery·Joshua D Nosanchuk
Feb 12, 2008·The Journal of Antimicrobial Chemotherapy·Matthew E FalagasPetros I Rafailidis
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hsin-Yun Sun, Nina Singh
Jul 10, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·László GalgóczyCsaba Vágvölgyi
Oct 31, 2009·Journal of Medical Microbiology·Ildikó NyilasiCsaba Vágvölgyi

❮ Previous
Next ❯

Citations

Mar 14, 2014·Cardiovascular Research·Emil KozarovLina Badimon
Nov 13, 2013·Expert Review of Anti-infective Therapy·Peter W Bergman, Linda Björkhem-Bergman
Nov 7, 2015·National Science Review·Sarita R ShahAntonios G Mikos
Jan 1, 2016·European Journal of Oral Sciences·Miriam TingJasim M Albandar
Jun 28, 2012·Journal of Basic Microbiology·Aaron R FarmerHeather C Yun
Jun 30, 2015·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Raimunda Sâmia Nogueira BrilhanteMarcos Fábio Gadelha Rocha
Jun 29, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yukihiro KanekoYoshitsugu Miyazaki
Jul 6, 2013·Microbiological Research·Ewa ObłąkJacek Luczyński
Nov 9, 2010·FEMS Microbiology Letters·Krisztina KrizsánTamás Papp
Jul 28, 2016·Virulence·Arielle ButtsP David Rogers
Sep 17, 2016·Scientific Reports·Suraj P PariharFrank Brombacher
Aug 2, 2012·Revista Do Instituto De Medicina Tropical De São Paulo·Everardo Albuquerque MenezesFrancisco Afrânio Cunha
May 22, 2013·Journal of the American Animal Hospital Association·Daniel K LangloisJohn M Kruger
Mar 5, 2019·Mycoses·Patrick SchwarzEric Dannaoui
Aug 29, 2019·Journal of Medical Microbiology·Ahmad AjdidiKevin Kavanagh
Apr 23, 2020·São Paulo Medical Journal = Revista Paulista De Medicina·Tássio Henrique Sousa SilvaFernanda Machado Fonseca
Aug 22, 2020·Medical Mycology·Ari Soares de Oliveira NetoMarcelo Gonzaga de Freitas Araújo
Nov 1, 2016·Expert Opinion on Therapeutic Targets·Meenakshi BalharaAnil K Chhillar
Nov 27, 2018·International Journal of Food Microbiology·Karla Paiva BocateLuciano Aparecido Panagio
Nov 19, 2020·Antibiotics·Jong H KimKirkwood M Land
Jan 19, 2020·Pharmacology & Therapeutics·Alireza TavakkoliAmirhossein Sahebkar
Jun 22, 2021·Applied Microbiology and Biotechnology·Qian ZhangZhangyong Song
Oct 12, 2021·World Journal of Microbiology & Biotechnology·Dina Ezzat MahmoudWael Mohamed Abu El-Wafa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.